S
Shifali
About Shifali
Data last updated:
Shifali is a Director at Zaneka Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Zaneka Pharmaceuticals Private Limited reported revenue of ₹4.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zaneka Pharmaceuticals Private Limited U24231UR1999PTC001430 | Director | 30 Jun 2011 | 1999 | ₹4.17 Cr (FY 2025) | Active |
Board colleagues of Shifali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Virmani | 03562939 | Zaneka Pharmaceuticals Private Limited | Director |
| Ashish Virmani | 01562520 | Zaneka Pharmaceuticals Private Limited | Director |
| Ashu Virmani | 09670602 | Zaneka Pharmaceuticals Private Limited | Director |
| Indu Batra | 07369263 | Zaneka Pharmaceuticals Private Limited | Director |
| Lalit Mohan Batra | 01562537 | Zaneka Pharmaceuticals Private Limited | Director |
| Satish Chand Virmani | 03562977 | Zaneka Pharmaceuticals Private Limited | Director |
| Shantanu Virmani | 03562960 | Zaneka Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shifali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shifali
Shifali currently holds 1 directorship: Zaneka Pharmaceuticals Private Limited (Director, since 30 Jun 2011, revenue ₹4.17 Cr (FY 2025)).
Shifali was first appointed on 30 Jun 2011 as Director at Zaneka Pharmaceuticals Private Limited.
The current boards of Shifali's companies include Amit Virmani (Zaneka Pharmaceuticals Private Limited), Ashish Virmani (Zaneka Pharmaceuticals Private Limited), Ashu Virmani (Zaneka Pharmaceuticals Private Limited), Indu Batra (Zaneka Pharmaceuticals Private Limited), Lalit Mohan Batra (Zaneka Pharmaceuticals Private Limited), Satish Chand Virmani (Zaneka Pharmaceuticals Private Limited), among others.